| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Ikaros Transcription Factor | 58 | 2024 | 230 | 5.920 |
Why?
|
| Precursor Cells, B-Lymphoid | 6 | 2023 | 94 | 2.040 |
Why?
|
| Lymphocytes | 24 | 2022 | 2600 | 1.950 |
Why?
|
| Transcription Factors | 49 | 2022 | 12123 | 1.630 |
Why?
|
| DNA-Binding Proteins | 42 | 2014 | 9594 | 1.600 |
Why?
|
| Chromatin | 13 | 2023 | 2981 | 1.490 |
Why?
|
| Mi-2 Nucleosome Remodeling and Deacetylase Complex | 8 | 2020 | 116 | 1.460 |
Why?
|
| Cell Differentiation | 45 | 2023 | 11641 | 1.420 |
Why?
|
| DNA Helicases | 8 | 2019 | 852 | 1.200 |
Why?
|
| Lymphopoiesis | 3 | 2014 | 132 | 1.020 |
Why?
|
| Hematopoietic Stem Cells | 18 | 2014 | 3406 | 1.010 |
Why?
|
| Enhancer Elements, Genetic | 10 | 2017 | 1365 | 0.980 |
Why?
|
| Cell Lineage | 15 | 2022 | 2573 | 0.900 |
Why?
|
| B-Lymphocytes | 13 | 2023 | 4779 | 0.870 |
Why?
|
| T-Lymphocytes | 27 | 2016 | 10262 | 0.850 |
Why?
|
| Gene Expression Regulation, Leukemic | 3 | 2021 | 658 | 0.830 |
Why?
|
| Genome | 5 | 2023 | 1752 | 0.820 |
Why?
|
| Trans-Activators | 14 | 2015 | 2850 | 0.800 |
Why?
|
| Adenosine Triphosphatases | 5 | 2008 | 837 | 0.790 |
Why?
|
| Hematopoiesis | 10 | 2023 | 2061 | 0.780 |
Why?
|
| Histone Deacetylases | 7 | 2009 | 714 | 0.710 |
Why?
|
| Gene Expression Regulation | 17 | 2024 | 11888 | 0.670 |
Why?
|
| Gene Expression Regulation, Developmental | 12 | 2019 | 3606 | 0.670 |
Why?
|
| Transcription, Genetic | 20 | 2021 | 7599 | 0.620 |
Why?
|
| Mice | 79 | 2024 | 81792 | 0.610 |
Why?
|
| Chromatin Assembly and Disassembly | 6 | 2023 | 632 | 0.610 |
Why?
|
| Transcription Factor AP-1 | 1 | 2020 | 322 | 0.600 |
Why?
|
| Gene Regulatory Networks | 4 | 2017 | 1747 | 0.590 |
Why?
|
| Zinc Fingers | 12 | 2002 | 576 | 0.570 |
Why?
|
| Keratinocytes | 3 | 2022 | 862 | 0.560 |
Why?
|
| Promoter Regions, Genetic | 15 | 2020 | 5787 | 0.550 |
Why?
|
| Repressor Proteins | 6 | 2016 | 2968 | 0.550 |
Why?
|
| Lymphocyte Activation | 15 | 2017 | 5501 | 0.540 |
Why?
|
| Animals | 95 | 2024 | 168731 | 0.530 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2017 | 2839 | 0.530 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 4 | 2013 | 792 | 0.520 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 | 2016 | 1559 | 0.510 |
Why?
|
| Receptors, Cytokine | 1 | 2017 | 258 | 0.510 |
Why?
|
| Precursor Cells, T-Lymphoid | 2 | 2014 | 19 | 0.490 |
Why?
|
| Thymus Gland | 15 | 2022 | 1260 | 0.490 |
Why?
|
| Cell Nucleus | 7 | 2018 | 2862 | 0.480 |
Why?
|
| Immunoglobulins | 3 | 2017 | 852 | 0.470 |
Why?
|
| Receptor, Notch1 | 2 | 2022 | 517 | 0.450 |
Why?
|
| Receptors, Antigen, T-Cell | 13 | 2016 | 2570 | 0.440 |
Why?
|
| Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 2 | 2021 | 230 | 0.430 |
Why?
|
| Epigenesis, Genetic | 5 | 2016 | 3818 | 0.430 |
Why?
|
| GATA3 Transcription Factor | 1 | 2013 | 163 | 0.410 |
Why?
|
| Transcriptional Activation | 4 | 2013 | 1743 | 0.400 |
Why?
|
| Actins | 1 | 2018 | 2056 | 0.370 |
Why?
|
| T-Lymphocytes, Regulatory | 3 | 2024 | 3110 | 0.350 |
Why?
|
| Mice, Transgenic | 13 | 2020 | 9548 | 0.350 |
Why?
|
| Immunity, Innate | 1 | 2022 | 3078 | 0.350 |
Why?
|
| Protein Isoforms | 6 | 2014 | 1718 | 0.340 |
Why?
|
| Mice, Knockout | 23 | 2024 | 14445 | 0.340 |
Why?
|
| Mitogen-Activated Protein Kinase 14 | 2 | 2022 | 29 | 0.330 |
Why?
|
| Base Sequence | 22 | 2015 | 12402 | 0.330 |
Why?
|
| Cell Proliferation | 7 | 2021 | 10428 | 0.300 |
Why?
|
| Myeloid Cells | 4 | 2013 | 839 | 0.300 |
Why?
|
| Mice, Inbred C57BL | 21 | 2024 | 22321 | 0.300 |
Why?
|
| Erythroid Precursor Cells | 2 | 2007 | 211 | 0.300 |
Why?
|
| Bone Marrow Cells | 8 | 2008 | 2412 | 0.290 |
Why?
|
| Cytokines | 4 | 2017 | 7424 | 0.290 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 7 | 1992 | 894 | 0.290 |
Why?
|
| Cells, Cultured | 13 | 2020 | 18972 | 0.290 |
Why?
|
| S Phase | 3 | 2004 | 424 | 0.280 |
Why?
|
| Flow Cytometry | 10 | 2015 | 5879 | 0.280 |
Why?
|
| Signal Transduction | 16 | 2023 | 23589 | 0.270 |
Why?
|
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2010 | 385 | 0.270 |
Why?
|
| Molecular Sequence Data | 21 | 2015 | 17595 | 0.270 |
Why?
|
| Skin | 1 | 2020 | 4474 | 0.260 |
Why?
|
| Hair Follicle | 2 | 2012 | 222 | 0.260 |
Why?
|
| Dendritic Cells | 5 | 2001 | 2746 | 0.260 |
Why?
|
| Homeostasis | 6 | 2020 | 3336 | 0.250 |
Why?
|
| Multipotent Stem Cells | 1 | 2007 | 200 | 0.250 |
Why?
|
| Antigen-Presenting Cells | 2 | 2009 | 962 | 0.250 |
Why?
|
| DNA Damage | 1 | 2015 | 2461 | 0.240 |
Why?
|
| SUMO-1 Protein | 1 | 2005 | 34 | 0.240 |
Why?
|
| G1 Phase | 2 | 2004 | 403 | 0.240 |
Why?
|
| Epithelial Cells | 1 | 2016 | 3683 | 0.230 |
Why?
|
| 3T3 Cells | 7 | 2002 | 1080 | 0.230 |
Why?
|
| Drosophila Proteins | 3 | 2000 | 1697 | 0.230 |
Why?
|
| Epidermis | 1 | 2007 | 535 | 0.220 |
Why?
|
| Neutrophils | 1 | 2017 | 3772 | 0.220 |
Why?
|
| Interleukin-10 | 1 | 2009 | 1183 | 0.210 |
Why?
|
| Protein Binding | 11 | 2017 | 9299 | 0.210 |
Why?
|
| Receptors, Interleukin-7 | 2 | 2021 | 41 | 0.210 |
Why?
|
| Multigene Family | 4 | 2003 | 1081 | 0.210 |
Why?
|
| Cell Cycle Proteins | 6 | 2023 | 3431 | 0.200 |
Why?
|
| Cell Cycle | 4 | 2009 | 2918 | 0.200 |
Why?
|
| Phosphoproteins | 2 | 2002 | 2445 | 0.200 |
Why?
|
| Mice, Inbred C3H | 3 | 2015 | 914 | 0.180 |
Why?
|
| Carrier Proteins | 4 | 2002 | 4912 | 0.180 |
Why?
|
| Plasma Cells | 1 | 2004 | 591 | 0.170 |
Why?
|
| Immune Tolerance | 1 | 2009 | 2324 | 0.160 |
Why?
|
| Binding Sites | 8 | 2015 | 6001 | 0.160 |
Why?
|
| DNA Primers | 5 | 2004 | 2823 | 0.160 |
Why?
|
| Corpus Striatum | 3 | 2012 | 1218 | 0.160 |
Why?
|
| Erythroid Cells | 1 | 2020 | 237 | 0.160 |
Why?
|
| Forkhead Transcription Factors | 2 | 2024 | 1624 | 0.160 |
Why?
|
| Lymphoid Tissue | 3 | 1998 | 444 | 0.160 |
Why?
|
| Monocytes | 3 | 2023 | 2594 | 0.160 |
Why?
|
| Enkephalins | 2 | 2010 | 139 | 0.150 |
Why?
|
| Stem Cells | 5 | 2010 | 3539 | 0.150 |
Why?
|
| Cell Survival | 3 | 2019 | 5747 | 0.150 |
Why?
|
| Autoantigens | 3 | 2014 | 883 | 0.150 |
Why?
|
| Spleen | 6 | 2001 | 2295 | 0.150 |
Why?
|
| Leukopoiesis | 1 | 1997 | 54 | 0.140 |
Why?
|
| Sequence Homology, Amino Acid | 4 | 2013 | 2744 | 0.140 |
Why?
|
| Interferon-gamma | 2 | 2024 | 3159 | 0.140 |
Why?
|
| Mitogen-Activated Protein Kinase 11 | 1 | 2016 | 5 | 0.140 |
Why?
|
| Immunoglobulin Light Chains | 2 | 2009 | 290 | 0.140 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2011 | 4405 | 0.140 |
Why?
|
| Green Fluorescent Proteins | 3 | 2015 | 2061 | 0.140 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2022 | 723 | 0.130 |
Why?
|
| Amino Acid Sequence | 13 | 2004 | 13403 | 0.130 |
Why?
|
| Muscle, Striated | 1 | 2016 | 17 | 0.130 |
Why?
|
| Autoimmunity | 1 | 2024 | 1354 | 0.130 |
Why?
|
| Mutation | 12 | 2021 | 30184 | 0.130 |
Why?
|
| Apoptosis | 8 | 2021 | 9511 | 0.130 |
Why?
|
| Chromosomes | 1 | 1999 | 578 | 0.130 |
Why?
|
| Cell Line | 12 | 2011 | 15542 | 0.130 |
Why?
|
| Nuclear Proteins | 4 | 2002 | 5781 | 0.130 |
Why?
|
| Leukemia, T-Cell | 1 | 1995 | 102 | 0.120 |
Why?
|
| Cloning, Molecular | 7 | 2002 | 4165 | 0.120 |
Why?
|
| Interleukin-2 | 3 | 2024 | 1896 | 0.120 |
Why?
|
| Dermatitis, Atopic | 1 | 2022 | 728 | 0.120 |
Why?
|
| Sequence Deletion | 4 | 2002 | 1493 | 0.120 |
Why?
|
| Humans | 50 | 2024 | 765734 | 0.120 |
Why?
|
| Centromere | 2 | 2006 | 213 | 0.120 |
Why?
|
| Vitamin D Deficiency | 1 | 2024 | 1349 | 0.120 |
Why?
|
| Cell Division | 5 | 2004 | 4472 | 0.110 |
Why?
|
| Cytoskeleton | 1 | 2018 | 1178 | 0.110 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2009 | 5336 | 0.110 |
Why?
|
| RNA, Messenger | 10 | 2003 | 12769 | 0.110 |
Why?
|
| Immunoblotting | 2 | 2014 | 1643 | 0.100 |
Why?
|
| Lymphoma, T-Cell | 1 | 1995 | 308 | 0.100 |
Why?
|
| Pneumonia | 1 | 2024 | 2156 | 0.100 |
Why?
|
| Antigens, CD34 | 2 | 2008 | 656 | 0.100 |
Why?
|
| Cell Separation | 2 | 2014 | 1718 | 0.100 |
Why?
|
| Huntington Disease | 1 | 2019 | 1147 | 0.100 |
Why?
|
| Bone Morphogenetic Protein Receptors, Type II | 1 | 2012 | 72 | 0.100 |
Why?
|
| Sin3 Histone Deacetylase and Corepressor Complex | 2 | 2002 | 19 | 0.100 |
Why?
|
| Antigens, CD | 3 | 2008 | 4020 | 0.100 |
Why?
|
| Hair Color | 1 | 2012 | 131 | 0.100 |
Why?
|
| Deoxyribonuclease I | 2 | 2011 | 228 | 0.090 |
Why?
|
| Adoptive Transfer | 1 | 2014 | 827 | 0.090 |
Why?
|
| Endothelium, Vascular | 1 | 2023 | 4423 | 0.090 |
Why?
|
| Macromolecular Substances | 4 | 1999 | 1430 | 0.090 |
Why?
|
| Brain Chemistry | 1 | 2014 | 952 | 0.090 |
Why?
|
| Microscopy, Fluorescence | 4 | 2012 | 2626 | 0.090 |
Why?
|
| Alcohol Oxidoreductases | 2 | 2002 | 164 | 0.090 |
Why?
|
| Histones | 5 | 2013 | 2592 | 0.090 |
Why?
|
| Colony-Forming Units Assay | 2 | 2001 | 351 | 0.080 |
Why?
|
| Cell Communication | 2 | 2017 | 1659 | 0.080 |
Why?
|
| Mice, Mutant Strains | 3 | 1999 | 1746 | 0.080 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 1999 | 1837 | 0.080 |
Why?
|
| Mutagenesis | 3 | 2002 | 1227 | 0.080 |
Why?
|
| MAP Kinase Signaling System | 1 | 2016 | 1489 | 0.080 |
Why?
|
| DNA Replication | 1 | 2017 | 1432 | 0.080 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2021 | 1644 | 0.080 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2014 | 2470 | 0.080 |
Why?
|
| Genomic Instability | 1 | 2013 | 718 | 0.080 |
Why?
|
| DNA | 10 | 2002 | 7200 | 0.080 |
Why?
|
| beta Catenin | 1 | 2013 | 1042 | 0.080 |
Why?
|
| Hair | 1 | 2012 | 508 | 0.080 |
Why?
|
| Silencer Elements, Transcriptional | 1 | 2007 | 10 | 0.070 |
Why?
|
| Gene Expression | 5 | 2007 | 7584 | 0.070 |
Why?
|
| Models, Immunological | 2 | 2004 | 517 | 0.070 |
Why?
|
| Tumor Cells, Cultured | 5 | 2021 | 6109 | 0.070 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2009 | 4563 | 0.070 |
Why?
|
| Gene Silencing | 3 | 2009 | 1505 | 0.070 |
Why?
|
| Ectoderm | 1 | 2007 | 138 | 0.070 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 2 | 2001 | 890 | 0.070 |
Why?
|
| Mice, Inbred NOD | 2 | 2021 | 1837 | 0.070 |
Why?
|
| Mice, Inbred Strains | 2 | 1999 | 1770 | 0.070 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 3 | 2012 | 1138 | 0.070 |
Why?
|
| Receptors, Transferrin | 1 | 2008 | 300 | 0.070 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2016 | 2794 | 0.060 |
Why?
|
| Neurons | 3 | 2012 | 9521 | 0.060 |
Why?
|
| Transfection | 3 | 2002 | 5744 | 0.060 |
Why?
|
| fms-Like Tyrosine Kinase 3 | 2 | 2000 | 497 | 0.060 |
Why?
|
| Klebsiella | 1 | 1985 | 49 | 0.060 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2006 | 220 | 0.060 |
Why?
|
| Th17 Cells | 1 | 2012 | 786 | 0.060 |
Why?
|
| Carbon-Nitrogen Lyases | 1 | 2005 | 8 | 0.060 |
Why?
|
| Amino Acid Motifs | 2 | 2015 | 924 | 0.060 |
Why?
|
| Homeodomain Proteins | 2 | 2012 | 2427 | 0.060 |
Why?
|
| Inflammation | 3 | 2024 | 10846 | 0.060 |
Why?
|
| Immunoprecipitation | 1 | 2007 | 871 | 0.060 |
Why?
|
| Asthma | 1 | 2024 | 6269 | 0.060 |
Why?
|
| Models, Genetic | 2 | 2013 | 3447 | 0.060 |
Why?
|
| Epigenomics | 1 | 2010 | 959 | 0.060 |
Why?
|
| Crosses, Genetic | 1 | 2006 | 752 | 0.060 |
Why?
|
| Synapses | 1 | 2014 | 1754 | 0.060 |
Why?
|
| Lymphoma | 1 | 2013 | 1896 | 0.060 |
Why?
|
| ras Proteins | 1 | 2009 | 1053 | 0.060 |
Why?
|
| Spondylitis, Ankylosing | 1 | 1985 | 157 | 0.060 |
Why?
|
| Phosphorylation | 3 | 2022 | 8279 | 0.060 |
Why?
|
| E1A-Associated p300 Protein | 1 | 2024 | 124 | 0.060 |
Why?
|
| Gene Expression Profiling | 2 | 2011 | 9522 | 0.060 |
Why?
|
| Casein Kinase II | 1 | 2004 | 120 | 0.050 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2005 | 431 | 0.050 |
Why?
|
| Somatic Hypermutation, Immunoglobulin | 1 | 2004 | 102 | 0.050 |
Why?
|
| Melanoma | 1 | 2022 | 5690 | 0.050 |
Why?
|
| Neurogenesis | 1 | 2010 | 865 | 0.050 |
Why?
|
| Leukemia | 1 | 2011 | 1522 | 0.050 |
Why?
|
| p300-CBP Transcription Factors | 1 | 2004 | 147 | 0.050 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2009 | 3794 | 0.050 |
Why?
|
| Acetyltransferases | 1 | 2004 | 229 | 0.050 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 1999 | 8603 | 0.050 |
Why?
|
| Sequence Alignment | 3 | 1998 | 2171 | 0.050 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2005 | 657 | 0.050 |
Why?
|
| Chimera | 1 | 2004 | 455 | 0.050 |
Why?
|
| Clone Cells | 2 | 1996 | 1672 | 0.050 |
Why?
|
| Heterochromatin | 1 | 2005 | 294 | 0.050 |
Why?
|
| Mink Cell Focus-Inducing Viruses | 1 | 2002 | 3 | 0.050 |
Why?
|
| Cell Fractionation | 2 | 2001 | 243 | 0.050 |
Why?
|
| Mice, Inbred BALB C | 3 | 2013 | 6219 | 0.050 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 2 | 2000 | 1622 | 0.050 |
Why?
|
| Histone Acetyltransferases | 1 | 2004 | 332 | 0.050 |
Why?
|
| Immunologic Deficiency Syndromes | 1 | 2006 | 547 | 0.050 |
Why?
|
| Recombinant Proteins | 3 | 2002 | 6492 | 0.050 |
Why?
|
| Gene Deletion | 3 | 2015 | 2666 | 0.050 |
Why?
|
| Sequence Homology, Nucleic Acid | 4 | 1991 | 1056 | 0.050 |
Why?
|
| Genetic Loci | 1 | 2010 | 2631 | 0.050 |
Why?
|
| Lymphocyte Specific Protein Tyrosine Kinase p56(lck) | 1 | 2001 | 93 | 0.050 |
Why?
|
| Receptors, Antigen, B-Cell | 2 | 2021 | 545 | 0.050 |
Why?
|
| Endodeoxyribonucleases | 1 | 2002 | 165 | 0.050 |
Why?
|
| Receptors, Complement 3d | 1 | 2001 | 116 | 0.050 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2002 | 3737 | 0.050 |
Why?
|
| Transgenes | 1 | 2004 | 1015 | 0.040 |
Why?
|
| Adenovirus E1A Proteins | 1 | 2000 | 81 | 0.040 |
Why?
|
| Proto-Oncogene Proteins | 3 | 2000 | 4520 | 0.040 |
Why?
|
| HLA Antigens | 1 | 1985 | 1338 | 0.040 |
Why?
|
| Antigens, Bacterial | 1 | 1985 | 1145 | 0.040 |
Why?
|
| Face | 1 | 2006 | 1028 | 0.040 |
Why?
|
| Retinoblastoma-Binding Protein 1 | 1 | 1999 | 137 | 0.040 |
Why?
|
| Transcription Factor DP1 | 1 | 1999 | 135 | 0.040 |
Why?
|
| Precipitin Tests | 1 | 2000 | 812 | 0.040 |
Why?
|
| Immunization | 1 | 2004 | 1218 | 0.040 |
Why?
|
| Stem Cell Factor | 1 | 2000 | 194 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 4 | 2002 | 6061 | 0.040 |
Why?
|
| Selection, Genetic | 1 | 2004 | 878 | 0.040 |
Why?
|
| Tissue Transplantation | 1 | 1999 | 128 | 0.040 |
Why?
|
| Phagocytes | 1 | 2001 | 292 | 0.040 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2001 | 4352 | 0.040 |
Why?
|
| Blood Cells | 1 | 2001 | 307 | 0.040 |
Why?
|
| Erythrocytes | 1 | 2008 | 2393 | 0.040 |
Why?
|
| E2F Transcription Factors | 1 | 1999 | 269 | 0.040 |
Why?
|
| Recombination, Genetic | 3 | 2013 | 1525 | 0.040 |
Why?
|
| Th2 Cells | 1 | 2024 | 1075 | 0.040 |
Why?
|
| Animals, Newborn | 3 | 2014 | 2670 | 0.040 |
Why?
|
| Dimerization | 2 | 1998 | 880 | 0.040 |
Why?
|
| Glutathione Transferase | 1 | 2000 | 562 | 0.040 |
Why?
|
| Interferons | 1 | 2022 | 714 | 0.040 |
Why?
|
| Yeasts | 1 | 1999 | 278 | 0.040 |
Why?
|
| Bone Marrow | 2 | 1999 | 2918 | 0.040 |
Why?
|
| Computational Biology | 1 | 2010 | 3558 | 0.040 |
Why?
|
| Radiation Chimera | 1 | 1997 | 216 | 0.040 |
Why?
|
| Thymoma | 2 | 1990 | 185 | 0.040 |
Why?
|
| Gene Targeting | 2 | 2005 | 841 | 0.040 |
Why?
|
| Immunologic Memory | 1 | 2004 | 1375 | 0.030 |
Why?
|
| Disease Models, Animal | 3 | 2019 | 18289 | 0.030 |
Why?
|
| Neprilysin | 1 | 2000 | 484 | 0.030 |
Why?
|
| Disease Progression | 1 | 2014 | 13614 | 0.030 |
Why?
|
| Egtazic Acid | 1 | 1996 | 165 | 0.030 |
Why?
|
| Sigmoidoscopes | 1 | 1996 | 5 | 0.030 |
Why?
|
| Acetylation | 1 | 1999 | 1056 | 0.030 |
Why?
|
| Lymphocyte Subsets | 1 | 1997 | 315 | 0.030 |
Why?
|
| Membrane Glycoproteins | 1 | 2007 | 3691 | 0.030 |
Why?
|
| Mice, SCID | 1 | 2021 | 2627 | 0.030 |
Why?
|
| Organ Specificity | 1 | 2001 | 1964 | 0.030 |
Why?
|
| Sigmoid Neoplasms | 1 | 1996 | 54 | 0.030 |
Why?
|
| Gastric Outlet Obstruction | 1 | 1996 | 55 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 1999 | 723 | 0.030 |
Why?
|
| Vitamins | 1 | 2024 | 1632 | 0.030 |
Why?
|
| Blotting, Northern | 3 | 1992 | 1546 | 0.030 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2005 | 1892 | 0.030 |
Why?
|
| Antigen Presentation | 1 | 2001 | 1250 | 0.030 |
Why?
|
| Nucleosomes | 1 | 1999 | 494 | 0.030 |
Why?
|
| Plasmids | 1 | 2000 | 2273 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 7 | 1 | 1996 | 311 | 0.030 |
Why?
|
| Receptors, Cell Surface | 2 | 2000 | 2817 | 0.030 |
Why?
|
| Chelating Agents | 1 | 1996 | 380 | 0.030 |
Why?
|
| Interleukins | 1 | 2000 | 791 | 0.030 |
Why?
|
| Leukemia-Lymphoma, Adult T-Cell | 1 | 1996 | 166 | 0.030 |
Why?
|
| Retinoblastoma-Binding Protein 4 | 1 | 2014 | 12 | 0.030 |
Why?
|
| Phenotype | 4 | 2019 | 16706 | 0.030 |
Why?
|
| Mitochondria, Heart | 1 | 2016 | 227 | 0.030 |
Why?
|
| Neoplasms | 2 | 2024 | 22345 | 0.030 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 1 | 1996 | 353 | 0.030 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 1999 | 778 | 0.030 |
Why?
|
| Genes, RAG-1 | 1 | 2013 | 67 | 0.030 |
Why?
|
| Stents | 2 | 1996 | 3213 | 0.030 |
Why?
|
| Conserved Sequence | 1 | 1997 | 1159 | 0.030 |
Why?
|
| Rats, Long-Evans | 1 | 2014 | 380 | 0.030 |
Why?
|
| T Cell Transcription Factor 1 | 1 | 2013 | 72 | 0.030 |
Why?
|
| Enzyme Inhibitors | 1 | 2004 | 3717 | 0.030 |
Why?
|
| Models, Biological | 3 | 1999 | 9441 | 0.030 |
Why?
|
| Nerve Tissue Proteins | 2 | 2019 | 4391 | 0.030 |
Why?
|
| Juvenile Hormones | 1 | 1992 | 15 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2021 | 3605 | 0.030 |
Why?
|
| Genes, Dominant | 1 | 1995 | 855 | 0.030 |
Why?
|
| Hepatocyte Nuclear Factor 1-alpha | 1 | 2013 | 175 | 0.030 |
Why?
|
| Erythropoiesis | 1 | 1996 | 691 | 0.030 |
Why?
|
| Blotting, Western | 1 | 2000 | 5019 | 0.030 |
Why?
|
| Exons | 2 | 1996 | 2391 | 0.030 |
Why?
|
| Melanosomes | 1 | 2012 | 34 | 0.030 |
Why?
|
| Purkinje Cells | 1 | 2014 | 228 | 0.030 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2015 | 856 | 0.030 |
Why?
|
| Genes, Homeobox | 1 | 1993 | 287 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2000 | 2926 | 0.020 |
Why?
|
| DNA, Complementary | 1 | 1996 | 1984 | 0.020 |
Why?
|
| Chromosome Aberrations | 1 | 1999 | 1774 | 0.020 |
Why?
|
| NF-kappa B | 1 | 2021 | 2486 | 0.020 |
Why?
|
| Chromosome Mapping | 2 | 2002 | 4618 | 0.020 |
Why?
|
| Genes, Tumor Suppressor | 1 | 1997 | 1059 | 0.020 |
Why?
|
| Zinc | 1 | 1996 | 675 | 0.020 |
Why?
|
| Activating Transcription Factor 2 | 1 | 1992 | 44 | 0.020 |
Why?
|
| Intestinal Obstruction | 1 | 1996 | 432 | 0.020 |
Why?
|
| Leucine Zippers | 1 | 1992 | 116 | 0.020 |
Why?
|
| Gene Frequency | 1 | 2019 | 3623 | 0.020 |
Why?
|
| Lymphoproliferative Disorders | 1 | 1995 | 526 | 0.020 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2001 | 2423 | 0.020 |
Why?
|
| Lymphoma, B-Cell | 1 | 1998 | 943 | 0.020 |
Why?
|
| Activin Receptors, Type II | 1 | 2012 | 122 | 0.020 |
Why?
|
| Antigens, Surface | 2 | 1986 | 1617 | 0.020 |
Why?
|
| DNA Restriction Enzymes | 2 | 1988 | 548 | 0.020 |
Why?
|
| CpG Islands | 1 | 2016 | 1207 | 0.020 |
Why?
|
| Genes, Reporter | 1 | 2015 | 1525 | 0.020 |
Why?
|
| Liver | 3 | 1998 | 7559 | 0.020 |
Why?
|
| RNA Splicing | 1 | 1996 | 904 | 0.020 |
Why?
|
| Mice, 129 Strain | 1 | 2012 | 369 | 0.020 |
Why?
|
| Intermediate Filament Proteins | 1 | 2012 | 261 | 0.020 |
Why?
|
| Palliative Care | 2 | 1996 | 3645 | 0.020 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2003 | 2155 | 0.020 |
Why?
|
| Vitamin D | 1 | 2024 | 3272 | 0.020 |
Why?
|
| Anemia | 1 | 1999 | 1510 | 0.020 |
Why?
|
| Receptors, Aryl Hydrocarbon | 1 | 2012 | 222 | 0.020 |
Why?
|
| Autoantibodies | 1 | 1998 | 2112 | 0.020 |
Why?
|
| Cyclin D3 | 1 | 2009 | 54 | 0.020 |
Why?
|
| Genes, cdc | 1 | 2010 | 113 | 0.020 |
Why?
|
| Alternative Splicing | 1 | 1994 | 1107 | 0.020 |
Why?
|
| Protein Biosynthesis | 1 | 1996 | 2086 | 0.020 |
Why?
|
| Efferent Pathways | 1 | 2010 | 164 | 0.020 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 1992 | 499 | 0.020 |
Why?
|
| DNA Breaks, Double-Stranded | 1 | 2013 | 605 | 0.020 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2009 | 295 | 0.020 |
Why?
|
| Forecasting | 1 | 1998 | 2936 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2010 | 372 | 0.020 |
Why?
|
| Melanocytes | 1 | 2012 | 503 | 0.020 |
Why?
|
| Heterozygote | 1 | 1995 | 2795 | 0.020 |
Why?
|
| Substance P | 1 | 2010 | 331 | 0.020 |
Why?
|
| STAT5 Transcription Factor | 1 | 2009 | 269 | 0.020 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 1999 | 2941 | 0.020 |
Why?
|
| T-Lymphocyte Subsets | 1 | 1996 | 1811 | 0.020 |
Why?
|
| Tissue Distribution | 1 | 1992 | 2266 | 0.020 |
Why?
|
| Saccharomyces cerevisiae | 1 | 1999 | 2677 | 0.020 |
Why?
|
| Lymph Nodes | 2 | 2002 | 3451 | 0.020 |
Why?
|
| Tubulin | 1 | 2012 | 692 | 0.020 |
Why?
|
| Genes | 2 | 1989 | 1824 | 0.020 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 2009 | 252 | 0.020 |
Why?
|
| Prognosis | 1 | 2009 | 29899 | 0.020 |
Why?
|
| STAT3 Transcription Factor | 1 | 2012 | 871 | 0.020 |
Why?
|
| Translocation, Genetic | 1 | 2013 | 1393 | 0.020 |
Why?
|
| Blotting, Southern | 1 | 1988 | 772 | 0.020 |
Why?
|
| Alleles | 1 | 2019 | 6893 | 0.020 |
Why?
|
| Alopecia | 1 | 2012 | 415 | 0.020 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2016 | 2056 | 0.020 |
Why?
|
| Immunoglobulin Light Chains, Surrogate | 1 | 2007 | 5 | 0.020 |
Why?
|
| Hybridomas | 1 | 1988 | 442 | 0.020 |
Why?
|
| Myocytes, Cardiac | 1 | 2016 | 1670 | 0.020 |
Why?
|
| Cyclins | 1 | 2009 | 598 | 0.020 |
Why?
|
| Thymus Neoplasms | 1 | 1990 | 270 | 0.020 |
Why?
|
| Rectal Neoplasms | 1 | 1996 | 1182 | 0.020 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2009 | 612 | 0.020 |
Why?
|
| Bromodeoxyuridine | 1 | 2007 | 310 | 0.020 |
Why?
|
| Brain | 1 | 2013 | 27178 | 0.020 |
Why?
|
| Embryo Loss | 1 | 2006 | 55 | 0.020 |
Why?
|
| Chemokine CCL19 | 1 | 2005 | 37 | 0.020 |
Why?
|
| Regulatory Elements, Transcriptional | 1 | 2007 | 183 | 0.020 |
Why?
|
| Germ-Line Mutation | 1 | 1994 | 1883 | 0.020 |
Why?
|
| HLA-B27 Antigen | 1 | 1985 | 66 | 0.020 |
Why?
|
| Stomach Neoplasms | 1 | 1996 | 1472 | 0.020 |
Why?
|
| Immune Sera | 1 | 1985 | 601 | 0.020 |
Why?
|
| Killer Cells, Natural | 1 | 1994 | 2207 | 0.020 |
Why?
|
| Drosophila | 1 | 1992 | 1501 | 0.010 |
Why?
|
| Rats | 2 | 2014 | 23704 | 0.010 |
Why?
|
| Macrophages | 1 | 2000 | 5772 | 0.010 |
Why?
|
| Chemokines, CC | 1 | 2005 | 285 | 0.010 |
Why?
|
| DNA Repair | 1 | 2013 | 2051 | 0.010 |
Why?
|
| Cerebellum | 1 | 2012 | 1519 | 0.010 |
Why?
|
| Genotype | 1 | 2019 | 13024 | 0.010 |
Why?
|
| Chemokines, CXC | 1 | 2005 | 416 | 0.010 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2011 | 4642 | 0.010 |
Why?
|
| Cardiomyopathies | 1 | 2016 | 2067 | 0.010 |
Why?
|
| Colitis | 1 | 2012 | 1239 | 0.010 |
Why?
|
| Chemokine CXCL12 | 1 | 2005 | 455 | 0.010 |
Why?
|
| Cross Reactions | 1 | 1985 | 824 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1985 | 1724 | 0.010 |
Why?
|
| Immune Complex Diseases | 1 | 2003 | 50 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2014 | 8102 | 0.010 |
Why?
|
| Heart | 1 | 2016 | 4417 | 0.010 |
Why?
|
| Age Factors | 1 | 1999 | 18375 | 0.010 |
Why?
|
| Mice, Inbred AKR | 1 | 2002 | 103 | 0.010 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2007 | 1065 | 0.010 |
Why?
|
| Serine | 1 | 2005 | 824 | 0.010 |
Why?
|
| Time Factors | 2 | 2011 | 40066 | 0.010 |
Why?
|
| Retroviridae Infections | 1 | 2002 | 149 | 0.010 |
Why?
|
| Leukemia, Experimental | 1 | 2002 | 225 | 0.010 |
Why?
|
| Antibodies, Antinuclear | 1 | 2003 | 340 | 0.010 |
Why?
|
| Male | 6 | 2015 | 363585 | 0.010 |
Why?
|
| Jurkat Cells | 1 | 2002 | 737 | 0.010 |
Why?
|
| Germinal Center | 1 | 2003 | 379 | 0.010 |
Why?
|
| Embryo, Mammalian | 1 | 2006 | 1673 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2007 | 3751 | 0.010 |
Why?
|
| 3' Untranslated Regions | 1 | 2002 | 515 | 0.010 |
Why?
|
| Syndrome | 1 | 2006 | 3268 | 0.010 |
Why?
|
| DNA Methylation | 1 | 2013 | 4425 | 0.010 |
Why?
|
| Female | 5 | 2015 | 395961 | 0.010 |
Why?
|
| Tumor Virus Infections | 1 | 2002 | 438 | 0.010 |
Why?
|
| Epistasis, Genetic | 1 | 2001 | 353 | 0.010 |
Why?
|
| Lymphocyte Count | 1 | 2001 | 789 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 1985 | 3805 | 0.010 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2002 | 1679 | 0.010 |
Why?
|
| Yolk Sac | 1 | 1998 | 79 | 0.010 |
Why?
|
| Pancreatic Neoplasms | 1 | 1996 | 5442 | 0.010 |
Why?
|
| Fibroblasts | 1 | 1988 | 4161 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 1996 | 9368 | 0.010 |
Why?
|
| Aging | 1 | 2016 | 8730 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2005 | 2454 | 0.010 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2007 | 2896 | 0.010 |
Why?
|
| Gastroscopy | 1 | 1996 | 213 | 0.010 |
Why?
|
| Adult | 2 | 2000 | 222974 | 0.010 |
Why?
|
| Microscopy, Confocal | 1 | 1998 | 1965 | 0.010 |
Why?
|
| Metals | 1 | 1996 | 710 | 0.010 |
Why?
|
| Multiple Myeloma | 1 | 1988 | 5195 | 0.010 |
Why?
|
| Calcimycin | 1 | 1989 | 214 | 0.010 |
Why?
|
| Antibodies | 1 | 1998 | 2416 | 0.010 |
Why?
|
| Cycloheximide | 1 | 1989 | 339 | 0.010 |
Why?
|
| Restriction Mapping | 1 | 1988 | 848 | 0.000 |
Why?
|
| Proto-Oncogene Proteins c-jun | 1 | 1988 | 287 | 0.000 |
Why?
|
| Equipment Design | 1 | 1996 | 3485 | 0.000 |
Why?
|
| Genes, Immunoglobulin | 1 | 1988 | 285 | 0.000 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 1989 | 394 | 0.000 |
Why?
|
| Immunoglobulin delta-Chains | 1 | 1986 | 7 | 0.000 |
Why?
|
| Chromosome Deletion | 1 | 1991 | 1385 | 0.000 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 1988 | 576 | 0.000 |
Why?
|
| Endoscopy | 1 | 1996 | 1849 | 0.000 |
Why?
|
| Cytoplasm | 1 | 1989 | 1497 | 0.000 |
Why?
|
| Introns | 1 | 1987 | 965 | 0.000 |
Why?
|
| Radiography | 1 | 1996 | 6917 | 0.000 |
Why?
|
| Structure-Activity Relationship | 1 | 1988 | 3054 | 0.000 |
Why?
|
| Genetic Linkage | 1 | 1987 | 2341 | 0.000 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 1986 | 1347 | 0.000 |
Why?
|
| Neoplasm Staging | 1 | 1996 | 11201 | 0.000 |
Why?
|
| DNA Mutational Analysis | 1 | 1988 | 4106 | 0.000 |
Why?
|
| Epitopes | 1 | 1986 | 2523 | 0.000 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 1986 | 1801 | 0.000 |
Why?
|
| Calcium | 1 | 1989 | 5765 | 0.000 |
Why?
|
| Follow-Up Studies | 1 | 1996 | 39180 | 0.000 |
Why?
|
| Aged | 2 | 1996 | 171050 | 0.000 |
Why?
|
| Middle Aged | 2 | 1996 | 222903 | 0.000 |
Why?
|
| Aged, 80 and over | 1 | 1996 | 59459 | 0.000 |
Why?
|
| Retrospective Studies | 1 | 1996 | 81457 | 0.000 |
Why?
|